Sorafenib might help overcome resistance to the aromatase inhibitors in patients with hormone receptor-positive MBC who have developed resistance to one of these agents. The Trials to Investigate ...

A CRISPR-Cas9 based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: cross-talk of FGF21 and the NRF2 pathway Science China Press Journal ...

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy ...